Delta hepatitis

Expert Review of Anti-Infective Therapy

Volumn 7, Issue 5, 2009, Pages 499-501

  Gunsar, Fulya ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALPHA INTERFERON; FAMCICLOVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS DELTA ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERFERON; LAMIVUDINE; PEGINTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

ANTIBODY DETECTION; ANTIVIRAL ACTIVITY; CANCER RISK; COMBINATION CHEMOTHERAPY; DELTA AGENT HEPATITIS; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; EDITORIAL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MONOTHERAPY; MORTALITY; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERINFECTION; TREATMENT DURATION; VACCINATION; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION; LIVER TUMOR; RISK FACTOR;

CARCINOMA, HEPATOCELLULAR; HEPATITIS B; HEPATITIS D; HUMANS; LIVER NEOPLASMS; RISK FACTORS; SUPERINFECTION;

EID: 68249149795     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/ERI.09.26     Document Type: Editorial

References (26)

1. Wu JC, Chen TZ, Huang YS et al. Natural history of hepatitis D viral superinfection: significance of viremia detected by polimerase chain reaction. Gastroenterology 108, 796-802 (1995).
2. Farci P. Delta heopatitis: an update. J. Hepatol. 39(Suppl. 1), 212-219 (2003).
3. Rizzetto M, Canase MG, Arico S et al. Immunofluorecence detectin of new antigen-antibody system (delta/antidelta) asociated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 18, 997-1003 (1977). (Pubitemid 8263407)
4. Lai MMC. The molecular biology of hepatitis delta virus. Ann. Rev. Biochem. 64, 259-286 (1995).
5. Sagnelli E, Stroffolini T, Ascione A et al. The epidemiology of hepatitis delta infection in Italy. Hepatology 15, 211-215 (1992).
6. Niro GA, Casey JL, Gravinese E et al. Intrafamilial transmission of hepatitis delta virus: molecular evidence. J. Hepatol. 30, 564-569 (1999). (Pubitemid 29151896)
7. Hsieh TH, Liu CJ, Chen PJ. Natural course and treatment of hepatitis D virus infection. J. Formos. Med. Assoc. 105, 869-881 (2006).
8. Rizzetto M, Hepatitis delta virus disease: an overview. Prog. Clin. Biol. Res. 382, 425-430 (1993). (Pubitemid 23114360)
9. Fattovich G, Giustina G, Christensen E, et al. Influence of hepatitis delta virus infection of morbity and mortality in compensated cirrhosis type B . The European Concerted Action on Viral Hepatitis (Eurohep). Gut 46, 420-426 (2000).
10. Borghesio E, Rosina F, Smedile A et al. Serum immuneglobuline M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon-treated patients and patients who underwent liver transplantation. Hepatology 27, 873-876 (1998). (Pubitemid 28103568)
11. Bichko V, Netter HJ, Wu TT et al. Pathogenesis associated with replication of hepatitis delta virus. Infect. Agents Dis. 3, 94-97 (1994). (Pubitemid 24280987)
12. Cole SM, Gowans EJ, MacNaughton TB, et al. Direct evidence for cytotoxicity associated with expression of hepatitis delta virus antigen. Hepatology 13, 845-851 (1991).
13. Niro GA, Rosina F, Rizetto M. Treatment of hepatitis D. J. Viral Hepat. 12, 2-9 (2005).
14. Farci P, mandas A, Coiana A et al. Treatment of chronic hepatitis D with interferon α-2a. N. Engl. J. Med. 330, 88-94 (1994).
15. Gaudin JL, Faure P, Godinot H, Gerard F, Trepo C. The French experience of treatment of chronic type D hepatitis with a 12 month course of interferon α-2B. Results of a randomized controlled trial. Liver 15, 45-52 (1995).
16. Madejon A, Cotonat T, Bartolome J et al. Treatment of chronic hepatitis D virus infection with low and high doses of interferon-α 2a: utility of polymerase chain reaction in monitoring antiviral response. Hepatology 19, 1331-1336 (1994). (Pubitemid 24978369)
17. Lau DTY, Kleiner DE, Park Y, Di Bisceglie AM, Hoofnagle JH. Resolution of chronic delta hepatitis after 12 years of interferon a therapy . Gastroenterology 117, 1229-1233 (1999). (Pubitemid 29512683)
18. Gunsar F, Akarca US, Ersoz G et al. Two-year interferon therapy with or without ribavirin in chronic delta hepatitis. Antivir. Ther. 10, 721-726 (2005). (Pubitemid 41376851)
19. Yurdaydin C, Bozkaya H, Karaaslan H et al. A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis. J. Viral Hepat. 14, 812-816 (2007). (Pubitemid 47561587)
20. Castenau C, Le Gal F, Ripault MP et al. Efficacy of peginterferon α-2b in chronic hepatitis deta: relevance of quantitative RT-PCR for follow up. Hepatology 44, 728-735 (2006). (Pubitemid 44433730)
21. Nio GA, Ciancio A, Gaeta GB et al. Pegylated interferon α-2b as monotharapy or in combination with ribavirin in chronic hepatitis delta. Hepatology 44, 713-720 (2006). (Pubitemid 44433728)
22. Rosshofer R, Choi S-S, Wolfl P, Roggendorf M. Interference of antiviral substances with replication of hepatitis delta virus RNA in primary woodchuck hepatocytes. Prog. Clin. Biol. Res. 364, 223-234 (1991).
23. Yurdaydin C, Bozkaya H, Onder FO et al. Tretment of chronic delta hepatitis with lamivudine vs lamivudine+interferon vs interferon. J. Viral Hepat. 15, 314-321 (2008). (Pubitemid 351326903)
24. Rizzetto M. Hepatitis D: thirty yeras after. J. Hepatol. 50(5), 1043-1050 (2009).
25. Pugnale P, Pazienza V, Gouilloux K, Negro F. Hepatitis delta virus inhibits α interferon signaling. Hepatology 49, 398-406 (2008).
26. Rizzetto M. Hepatitis D: the comeback? Liver Int. 29, 140-142 (2009).